Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GLP-1 and Fatty Liver Disease (NAFLD/NASH) GLP-1RAs show promising benefits in: Hepatic steatosis reduction Weight loss-mediated liver improvement Improved insulin resistance Reduced inflammation These agents are likely to become central therapies in metabolic-associated steatotic liver disease (MASLD)
Stronger hair
-
DOI: Published: Publisher Name: Springer, Singapore Print ISBN: 978-981-95-7796-5 Online ISBN: 978-981-95-7797-2 eBook Packages: MedicineMedicine (R0)
doi: 10.1038/s41387-022-00209-z 33
Keep out of reach and sight of young children
US$ 21.83
US$ 20.02
US$ 21.99
US$ 21.95
